Ionis Pharmaceuticals Inc (NASDAQ:IONS)

53.38
Delayed Data
As of 3:59pm ET
 -0.74 / -1.37%
Today’s Change
39.32
Today|||52-Week Range
73.09
-11.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.9B

Company Description

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Contact Information

Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad California 92010
P:(760) 931-9200
Investor Relations:
(760) 603-2331

Employees

Shareholders

Mutual fund holders52.95%
Other institutional32.88%
Individual stakeholders0.86%

Top Executives

Brett P. MoniaChief Executive Officer & Director
Joel EdwardsVice President-Corporate & Commercial Operations
Elizabeth L. HougenChief Financial Officer & SVP-Finance
C. Frank BennettChief Scientific Officer
Sanjay BhanotChief Medical Officer